Skip to main content
Erschienen in: General Thoracic and Cardiovascular Surgery 12/2018

15.09.2018 | Original Article

Salvage esophagectomy combined with partial aortic wall resection following thoracic endovascular aortic repair

verfasst von: Masanobu Nakajima, Hiroto Muroi, Maiko Kikuchi, Satoru Yamaguchi, Kinro Sasaki, Takashi Tsuchioka, Yusuke Takei, Ikuko Shibasaki, Hirotsugu Fukuda, Hiroyuki Kato

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

Definitive chemoradiotherapy is useful for locally advanced esophageal cancer. However, salvage esophagectomy is required when residual or recurrent tumor is evident after chemoradiotherapy. We performed salvage esophagectomy combined with partial aortic wall resection after thoracic endovascular aortic repair for aortic invasion, and we evaluated the results.

Methods

Four patients underwent esophagectomy combined with aortic wall resection after thoracic endovascular aortic repair because the lesion was diagnosed as stage T4b. We evaluated short-term outcomes, including duration of thoracic surgery, blood loss, duration of intubation, intensive care unit stay, and postoperative morbidity, as well as survival after salvage surgery.

Results

Lesions were resected with no intraoperative procedural adverse events. Mean thoracic operation time was 444 min, and mean thoracic blood loss was 506 g. In all patients, complete resection of the lesion was possible with no intraoperative adverse events. All patients were extubated on postoperative day 0, and all were discharged from the intensive care unit on postoperative day 1. One patient experienced grade II wound pain (bilateral chest pain), and another patient experienced difficult sputum expectoration (grade IIIA). The mean follow-up time was 19.8 months, and two patients were alive with no disease recurrence at the time of this report. However, the remaining two patients had died secondary to lymph node metastasis.

Conclusions

Salvage esophagectomy combined with partial aortic wall resection after thoracic endovascular aortic repair provides acceptable short-term outcomes. Future studies are needed to evaluate long-term survival and patient selection criteria.
Literatur
1.
Zurück zum Zitat Fujita H. A history of surgery for locally-advanced (T4) cancer of the thoracic esophagus in Japan and a personal perspective. Ann Thorac Cardiovasc Surg. 2013;19:409–15.CrossRef Fujita H. A history of surgery for locally-advanced (T4) cancer of the thoracic esophagus in Japan and a personal perspective. Ann Thorac Cardiovasc Surg. 2013;19:409–15.CrossRef
2.
Zurück zum Zitat Tachimori Y, Ozawa S, Numasaki H, Ishihara R, Matsubara H, Muro K, et al. Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Comprehensive Registry of Esophageal Cancer in Japan, 2010. Esophagus. 2017;14:189–214.CrossRef Tachimori Y, Ozawa S, Numasaki H, Ishihara R, Matsubara H, Muro K, et al. Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Comprehensive Registry of Esophageal Cancer in Japan, 2010. Esophagus. 2017;14:189–214.CrossRef
3.
Zurück zum Zitat Shinoda M, Ando N, Kato K, Ishikura S, Kato H, Tsubosa Y, et al. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303). Cancer Sci. 2015;106:407–12.CrossRef Shinoda M, Ando N, Kato K, Ishikura S, Kato H, Tsubosa Y, et al. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303). Cancer Sci. 2015;106:407–12.CrossRef
4.
Zurück zum Zitat Rees J, Hurt CN, Gollins S, Mukherjee S, Maughan T, Falk SJ, et al. Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. Br J Cancer. 2015;113:603–10.CrossRef Rees J, Hurt CN, Gollins S, Mukherjee S, Maughan T, Falk SJ, et al. Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. Br J Cancer. 2015;113:603–10.CrossRef
5.
Zurück zum Zitat Watanabe M, Mine S, Yamada K, Shigaki H, Baba Y, Yoshida N, et al. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg. 2014;62:685–92.CrossRef Watanabe M, Mine S, Yamada K, Shigaki H, Baba Y, Yoshida N, et al. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg. 2014;62:685–92.CrossRef
6.
Zurück zum Zitat Tachimori Y. Role of salvage esophagectomy after definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg. 2009;57:71–8.CrossRef Tachimori Y. Role of salvage esophagectomy after definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg. 2009;57:71–8.CrossRef
7.
Zurück zum Zitat Nakajima M, Kato H, Muroi H, Kikuchi M, Takahashi M, Yamaguchi S, et al. Minimally invasive salvage operations for esophageal cancer after definitive chemoradiotherapy. Digestion. 2018;97:64–9.CrossRef Nakajima M, Kato H, Muroi H, Kikuchi M, Takahashi M, Yamaguchi S, et al. Minimally invasive salvage operations for esophageal cancer after definitive chemoradiotherapy. Digestion. 2018;97:64–9.CrossRef
8.
Zurück zum Zitat Matsumoto A, Kanaoka Y, Baba T, Takizawa R, Hara M, Maeda K, et al. Result of thoracic endovascular aortic repair for patients with esophageal cancer. World J Surg. 2017;42:1551–8.CrossRef Matsumoto A, Kanaoka Y, Baba T, Takizawa R, Hara M, Maeda K, et al. Result of thoracic endovascular aortic repair for patients with esophageal cancer. World J Surg. 2017;42:1551–8.CrossRef
9.
Zurück zum Zitat Ferrero E, Viazzo A, Ferri M, Rocca R, Pecchio A, Piazza S, et al. Acute management of aortoesophageal fistula and tracheoesophageal fistula treated by thoracic endovascular aortic repair and esophageal endoprosthesis: a case misdiagnosed as esophageal cancer. Ann Vasc Surg. 2011;25:1142.e1–5. Ferrero E, Viazzo A, Ferri M, Rocca R, Pecchio A, Piazza S, et al. Acute management of aortoesophageal fistula and tracheoesophageal fistula treated by thoracic endovascular aortic repair and esophageal endoprosthesis: a case misdiagnosed as esophageal cancer. Ann Vasc Surg. 2011;25:1142.e1–5.
10.
Zurück zum Zitat Matono S, Fujita H, Tanaka T, Nagano T, Nishimura K, Murata K, et al. Thoracic endovascular aortic repair for aortic complications after esophagectomy for cancer: report of three cases. Dis Esophagus. 2011;24:E36–40.CrossRef Matono S, Fujita H, Tanaka T, Nagano T, Nishimura K, Murata K, et al. Thoracic endovascular aortic repair for aortic complications after esophagectomy for cancer: report of three cases. Dis Esophagus. 2011;24:E36–40.CrossRef
11.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. ed 7. Oxford: Wiley-Blackwell; 2010. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. ed 7. Oxford: Wiley-Blackwell; 2010.
12.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRef Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRef
13.
Zurück zum Zitat Kato H, Nakajima M. Treatments for esophageal cancer: a review. Gen Thorac Cardiovasc Surg. 2013;61:330–5.CrossRef Kato H, Nakajima M. Treatments for esophageal cancer: a review. Gen Thorac Cardiovasc Surg. 2013;61:330–5.CrossRef
14.
Zurück zum Zitat Akutsu Y, Matsubara H. Chemoradiotherapy and surgery for T4 esophageal cancer in Japan. Surg Today. 2015;45:1360–5.CrossRef Akutsu Y, Matsubara H. Chemoradiotherapy and surgery for T4 esophageal cancer in Japan. Surg Today. 2015;45:1360–5.CrossRef
15.
Zurück zum Zitat Jamel S, Markar SR. Salvage esophagectomy: safe therapeutic strategy? J Thorac Dis. 2017;9:799–808.CrossRef Jamel S, Markar SR. Salvage esophagectomy: safe therapeutic strategy? J Thorac Dis. 2017;9:799–808.CrossRef
16.
Zurück zum Zitat Swisher SG, Marks J, Rice D. Salvage esophagectomy for persistent or recurrent disease after definitive chemoradiation. Ann Cardiothorac Surg. 2017;6:144–51.CrossRef Swisher SG, Marks J, Rice D. Salvage esophagectomy for persistent or recurrent disease after definitive chemoradiation. Ann Cardiothorac Surg. 2017;6:144–51.CrossRef
17.
Zurück zum Zitat Shimizu H, Hirahara N, Motomura N, Miyata H, Takamoto S. Current status of cardiovascular surgery in Japan, 2013 and 2014: a report based on the Japan Cardiovascular Surgery Database 5. Thoracic aortic surgery. Gen Thorac Cardiovasc Surg. 2017;65:671–8.CrossRef Shimizu H, Hirahara N, Motomura N, Miyata H, Takamoto S. Current status of cardiovascular surgery in Japan, 2013 and 2014: a report based on the Japan Cardiovascular Surgery Database 5. Thoracic aortic surgery. Gen Thorac Cardiovasc Surg. 2017;65:671–8.CrossRef
18.
Zurück zum Zitat Matsuda H. Treatment of uncomplicated type B aortic dissection. Gen Thorac Cardiovasc Surg. 2017;65:74–9.CrossRef Matsuda H. Treatment of uncomplicated type B aortic dissection. Gen Thorac Cardiovasc Surg. 2017;65:74–9.CrossRef
19.
Zurück zum Zitat Chuter TA, Ivancev K, Lindblad B, Brunkwall J, Arén C, Risberg B. Endovascular stentgraft exclusion of an aortobronchial fistula. J Vasc Interv Radiol. 1996;7:357–9.CrossRef Chuter TA, Ivancev K, Lindblad B, Brunkwall J, Arén C, Risberg B. Endovascular stentgraft exclusion of an aortobronchial fistula. J Vasc Interv Radiol. 1996;7:357–9.CrossRef
20.
Zurück zum Zitat Ishikawa N, Maruta K, Oi M, Iizuka H, Kawaura H, Omoto T. Thoracic endovascular repair for aorto-esophageal fistula in patients with esophageal carcinoma: report of 3 cases. Vasc Endovascular Surg. 2013;47:65–9.CrossRef Ishikawa N, Maruta K, Oi M, Iizuka H, Kawaura H, Omoto T. Thoracic endovascular repair for aorto-esophageal fistula in patients with esophageal carcinoma: report of 3 cases. Vasc Endovascular Surg. 2013;47:65–9.CrossRef
21.
Zurück zum Zitat Okita Y, Yamanaka K, Okada K, Matsumori M, Inoue T, Fukase K, et al. Strategies for the treatment of aorto-oesophageal fistula. Eur J Cardiothorac Surg. 2014;46:894–900.CrossRef Okita Y, Yamanaka K, Okada K, Matsumori M, Inoue T, Fukase K, et al. Strategies for the treatment of aorto-oesophageal fistula. Eur J Cardiothorac Surg. 2014;46:894–900.CrossRef
22.
Zurück zum Zitat Matsumoto A, Kanaoka Y, Baba T, Takizawa R, Hara M, Maeda K, et al. Result of thoracic endovascular aortic repair for patients with esophageal cancer. World J Surg. 2018;42:1551–8.CrossRef Matsumoto A, Kanaoka Y, Baba T, Takizawa R, Hara M, Maeda K, et al. Result of thoracic endovascular aortic repair for patients with esophageal cancer. World J Surg. 2018;42:1551–8.CrossRef
23.
Zurück zum Zitat Makino T, Yasuda T, Shiraishi O, Shiozaki H. Aortic stent-grafting facilitates a successful resection after neoadjuvant treatment of a cT4 esophageal cancer. J Thorac Cardiovasc Surg. 2014;148:e211-2.CrossRef Makino T, Yasuda T, Shiraishi O, Shiozaki H. Aortic stent-grafting facilitates a successful resection after neoadjuvant treatment of a cT4 esophageal cancer. J Thorac Cardiovasc Surg. 2014;148:e211-2.CrossRef
24.
Zurück zum Zitat Watanabe Y, Kashihara S, Kiyonari N, Tsuji Y, Hisano K, Okada M. Combined resection of the thoracic esophagus and thoracic descending aorta. Jpn J Thorac Cardiovasc Surg. 1999;47:495–8.CrossRef Watanabe Y, Kashihara S, Kiyonari N, Tsuji Y, Hisano K, Okada M. Combined resection of the thoracic esophagus and thoracic descending aorta. Jpn J Thorac Cardiovasc Surg. 1999;47:495–8.CrossRef
25.
Zurück zum Zitat Sasahara H, Sueyoshi S, Tanaka T, Fujita H, Shirouzu K. Evaluation of an aortic stent graft for use in surgery on esophageal cancer involving the thoracic aorta: experimental study. Jpn J Thorac Cardiovasc Surg. 2004;52:231–9.CrossRef Sasahara H, Sueyoshi S, Tanaka T, Fujita H, Shirouzu K. Evaluation of an aortic stent graft for use in surgery on esophageal cancer involving the thoracic aorta: experimental study. Jpn J Thorac Cardiovasc Surg. 2004;52:231–9.CrossRef
26.
Zurück zum Zitat Cohen C, Tessier W, Gronnier C, Renaud F, Pasquer A, Théreaux J, et al. FREGAT (French Eso-Gastric Tumors working group)—FRENCH (Fédération de Recherche en Chirurgie)—AFC (Association Française de Chirurgie). Salvage surgery for esophageal cancer: how to improve outcomes? Ann Surg Oncol. 2018;25:1277–86.CrossRef Cohen C, Tessier W, Gronnier C, Renaud F, Pasquer A, Théreaux J, et al. FREGAT (French Eso-Gastric Tumors working group)—FRENCH (Fédération de Recherche en Chirurgie)—AFC (Association Française de Chirurgie). Salvage surgery for esophageal cancer: how to improve outcomes? Ann Surg Oncol. 2018;25:1277–86.CrossRef
27.
Zurück zum Zitat Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRef Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRef
Metadaten
Titel
Salvage esophagectomy combined with partial aortic wall resection following thoracic endovascular aortic repair
verfasst von
Masanobu Nakajima
Hiroto Muroi
Maiko Kikuchi
Satoru Yamaguchi
Kinro Sasaki
Takashi Tsuchioka
Yusuke Takei
Ikuko Shibasaki
Hirotsugu Fukuda
Hiroyuki Kato
Publikationsdatum
15.09.2018
Verlag
Springer Japan
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 12/2018
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-018-1013-z

Weitere Artikel der Ausgabe 12/2018

General Thoracic and Cardiovascular Surgery 12/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.